BMRN — BIOMARIN PHARMACEUTICAL ICOM

Ownership history in AVIVA PLC  ·  52 quarters on record

This page tracks every 13F SEC filing in which AVIVA PLC reported a position in BIOMARIN PHARMACEUTICAL ICOM (BMRN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.08% (2015 Q2)
Avg. % of fund
0.03%
First filed
2010 Q1
Last filed
2025 Q3
Quarters held
52
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 62,431 +1,352 +2.2% 0.01% $3.4M $54.16
2025 Q2 ADDED 61,079 +54,069 +771.3% 0.01% $3.4M $54.97
2025 Q1 REDUCED 7,010 -102 -1.4% 0.00% $496K $70.69
2024 Q4 UNCHANGED 7,112 — 0% 0.00% $467K $65.73
48 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    BMRN price (monthly, adj. close)

Other funds also holding BMRN

As of 2025 Q4 — sorted by position size

Krensavage Asset Management, LLC 3Y 7Y 11.02% BOONE CAPITAL MANAGEMENT LLC 3Y 7.68% Palo Alto Investors LP 3Y 7Y 6.17% Vestal Point Capital, LP 6.06% Eagle Health Investments LP 3Y 4.79% Novo Holdings A/S 3Y 7Y 3.05% Soleus Capital Management, L.P. 3Y 2.89% SECTOR GAMMA AS 3Y 7Y 2.69% Deep Track Capital, LP 3Y 2.44% Sio Capital Management, LLC 3Y 7Y 2.18%
← Back to AVIVA PLC Holdings